Blog

Meet CRCHD grantee Dr. Diane Mahoney, interested in studying factors that contribute to higher ovarian cancer death rates among Black women – NCI Center to Reduce Cancer Health Disparities (CRCHD)

Photo taken from: NCI Center to Reduce Cancer Health Disparities (CRCHD)/LinkedIn

Mar 13, 2024, 17:05

Meet CRCHD grantee Dr. Diane Mahoney, interested in studying factors that contribute to higher ovarian cancer death rates among Black women – NCI Center to Reduce Cancer Health Disparities (CRCHD)

NCI Center to Reduce Cancer Health Disparities (CRCHD) shared on LinkedIn:

“Meet CRCHD grantee Dr. Diane Mahoney, who is interested in studying factors that contribute to higher ovarian cancer death rates among Black women. Her current research focuses on the discovery and development of screening tests for the early detection of ovarian cancer.

Diane credits the National Cancer Institute (NCI) Diversity Supplement for opening many doors throughout her career. Interested in learning more or applying for NCI’s Diversity Supplement? Visit our website! Applications are due by March 31, 2024.”

Read further.
Source: NCI Center to Reduce Cancer Health Disparities (CRCHD)/LinkedIn

cancer CRCHD Dr. Diane Mahoney National Cancer Institute (NCI) NCI Center to Reduce Cancer Health Disparities (CRCHD) OncoDaily Oncology Ovarian Cancer

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot